Evidence map›Paper›PMID 32303726›Full record

ArticleNature immunology2020

Publisher Correction: Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly.

Roel P H De Maeyer, Rachel C van de Merwe, Rikah Louie, Olivia V Bracken, Oliver P Devine, Daniel R Goldstein, Mohib Uddin, Arne N Akbar, Derek W Gilroy

Open access · bronzeAbstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Roel P H De Maeyer *Division of Medicine, University College London, London, UK.ORCID http://orcid.org/0000-0003-4041-0867
Rachel C van de Merwe *Division of Medicine, University College London, London, UK.
Rikah LouieDivision of Medicine, University College London, London, UK.
Olivia V BrackenDivision of Medicine, University College London, London, UK.
Oliver P DevineDivision of Infection and Immunity, University College London, London, UK.
Daniel R GoldsteinDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.ORCID http://orcid.org/0000-0001-6695-979X
Mohib UddinRespiratory Global Medicines Development, AstraZeneca, Gothenburg, Sweden.ORCID http://orcid.org/0000-0002-2412-2657
Arne N AkbarDivision of Infection and Immunity, University College London, London, UK.ORCID http://orcid.org/0000-0002-3763-9380
Derek W GilroyDivision of Medicine, University College London, London, UK. d.gilroy@ucl.ac.uk.ORCID http://orcid.org/0000-0003-3476-0844
University College London · GBAstraZeneca (Sweden) · SEThe London College · GBUniversity of Michigan · US

Funding

Mechanisms to augment primary immunity in agingR01AG028082 · NIA · YALE UNIVERSITY · PI DENG, JANE C · 2007 to 2023
$6.9M
Novel Inflammatory Pathway of Aged-Enhanced AtherosclerosisR01HL127687 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI GOLDSTEIN, DANIEL ROBERT · 2016 to 2019
$1.6M
Medical Research Council MR/M003833/1NHLBI NIH HHS R01 HL127687
6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32303726
OpenAlexW3016353771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.